Mealey's (April 24, 2020, 10:39 AM EDT) -- DENVER — Finding that the Drug Enforcement Administration sufficiently established that several years’ worth of patient prescription data it seeks via subpoenas has a reasonable relevance to an investigation over the distribution of controlled substances, a Colorado federal judge on April 21 granted the agency’s request to enforce compliance with the subpoenas by the Colorado Board of Pharmacy, which raised privacy concerns (U.S. Department of Justice, Drug Enforcement Administration v. Colorado Board of Pharmacy, et al., No. 1:19-cv-00105, D. Colo., 2020 U.S. Dist. LEXIS 69726)....